Trexquant Investment LP Celldex Therapeutics, Inc. Transaction History
Trexquant Investment LP
- $8.35 Billion
- Q2 2025
A detailed history of Trexquant Investment LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 112,464 shares of CLDX stock, worth $3.11 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
112,464
Previous 78,210
43.8%
Holding current value
$3.11 Million
Previous $1.42 Million
61.24%
% of portfolio
0.03%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding CLDX
# of Institutions
201Shares Held
68.3MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$169 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$145 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$109 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$106 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.29B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...